Your browser doesn't support javascript.
loading
Administration of Gapmer-type Antisense Oligonucleotides Targeting γ-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts.
Ii, Hiromi; Kasahara, Yuuya; Yamaguma, Harumi; Kageyama, Susumu; Kawauchi, Akihiro; Obika, Satoshi; Nakata, Susumu.
Affiliation
  • Ii H; Department of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan.
  • Kasahara Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Yamaguma H; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
  • Kageyama S; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
  • Kawauchi A; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
  • Obika S; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
  • Nakata S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan; obika@phs.osaka-u.ac.jp.
Anticancer Res ; 42(3): 1221-1227, 2022 03.
Article in En | MEDLINE | ID: mdl-35220212
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides, Antisense / Cell Proliferation / Gamma-Glutamylcyclotransferase / Lung Neoplasms / Antineoplastic Agents Limits: Animals / Humans / Male Language: En Journal: Anticancer Res Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligonucleotides, Antisense / Cell Proliferation / Gamma-Glutamylcyclotransferase / Lung Neoplasms / Antineoplastic Agents Limits: Animals / Humans / Male Language: En Journal: Anticancer Res Year: 2022 Document type: Article